In Black South Africans from Rural and Urban Communities, the 4G/5G PAI-1 Polymorphism Influences PAI-1 Activity, but Not Plasma Clot Lysis Time

被引:6
|
作者
de Lange, Zelda [1 ]
Rijken, Dingeman C. [2 ]
Hoekstra, Tiny [1 ,3 ]
Conradie, Karin R. [1 ]
Jerling, Johann C. [1 ]
Pieters, Marlien [1 ]
机构
[1] North West Univ, Ctr Excellence Nutr, Potchefstroom, South Africa
[2] Erasmus Univ, Med Ctr, Dept Haematol, Rotterdam, Netherlands
[3] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands
来源
PLOS ONE | 2013年 / 8卷 / 12期
基金
新加坡国家研究基金会; 英国医学研究理事会;
关键词
PLASMINOGEN-ACTIVATOR INHIBITOR-1; MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE; VENOUS THROMBOSIS; INCOME COUNTRIES; CORONARY ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; CIRCULATING LEVELS; METABOLIC SYNDROME; ADIPOSE-TISSUE;
D O I
10.1371/journal.pone.0083151
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Data on genetic and environmental factors influencing PAI-1 levels and their consequent effect on clot lysis in black African populations are limited. We identified polymorphisms in the promoter area of the PAI-1 gene and determined their influence on PAI-1(act) levels and plasma clot lysis time (CLT). We also describe gene-environment interactions and the effect of urbanisation. Data from 2010 apparently healthy urban and rural black participants from the South African arm of the PURE study were cross-sectionally analysed. The 5G allele frequency of the 4G/5G polymorphism was 0.85. PAI-1(act) increased across genotypes in the urban subgroup (p = 0.009) but not significantly in the rural subgroup, while CLT did not differ across genotypes. Significant interaction terms were found between the 4G/5G polymorphism and BMI, waist circumference and triglycerides in determining PAI-1(act), and between the 4G/5G polymorphism and fibrinogen and fibrinogen gamma prime in determining CLT. The C428T and G429A polymorphisms did not show direct relationships with PAI-1(act) or CLT but they did influence the association of other environmental factors with PAI-1(act) and CLT. Several of these interactions differed significantly between rural and urban subgroups, particularly in individuals harbouring the mutant alleles. In conclusion, although the 4G/5G polymorphism significantly affected PAI-1(act), it contributed less than 1% to the PAI-1(act) variance. (Central) obesity was the biggest contributor to PAI-1(act) variance (12.5%). Urbanisation significantly influenced the effect of the 4G/5G polymorphism on PAI-1(act) as well as gene-environment interactions for the C428T and G429A genotypes in determining PAI-1(act) and CLT.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] The impact of the PAI-1 4G/5G polymorphism on the outcome of patients with ALI/ARDS
    Tsangaris, Iraklis
    Tsantes, Argiris
    Bonovas, Stefanos
    Lignos, Michalis
    Kopterides, Petros
    Gialeraki, Argiro
    Rapti, Evdoxia
    Orfanos, Stylianos
    Dimopoulou, Ioanna
    Travlou, Anthi
    Armaganidis, Apostolos
    THROMBOSIS RESEARCH, 2009, 123 (06) : 832 - 836
  • [32] PAI-1 −675 4G/5G polymorphism as a prognostic biomarker in breast cancer
    Haixin Lei
    Kari Hemminki
    Robert Johansson
    Andrea Altieri
    Kerstin Enquist
    Roger Henriksson
    Per Lenner
    Asta Försti
    Breast Cancer Research and Treatment, 2008, 109 : 165 - 175
  • [33] 4G/5G polymorphism modulates PAI-1 circulating levels in obese women
    Karla S. Fernandes
    Valéria C. Sandrim
    Molecular and Cellular Biochemistry, 2012, 364 : 299 - 301
  • [34] Diabetic microangiopathy and 4G/5G polymorphism of the PAI-1 gene promoter in IDDM
    Pucci, L
    Pilo, M
    Bandinelli, S
    Navalesi, R
    Penno, G
    DIABETES, 1999, 48 : A153 - A153
  • [35] PAI-1 4G/5G Polymorphism and Plasma Levels Association in Patients with Coronary Artery Disease
    Lima, Luciana Moreira
    Carvalho, Maria das Gracas
    Fonseca Neto, Cirilo Pereira
    Faria Garcia, Jose Carlos
    Sousa, Marinez Oliveira
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2011, 97 (06) : 462 - 467
  • [36] The plasminogen activator inhibitor-1 (PAI-1) gene −844 A/G and −675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome
    Sun Lin
    Zhang Huiya
    Liu Bo
    Wei Wei
    Guan Yongmei
    Endocrine, 2009, 36 : 503 - 509
  • [37] Interrelationship between ACE I/D and PAI-1 4G/5G polymorphisms on plasma PAI-1 antigen levels in healthy subjects
    dAddedda, M
    Cappucci, G
    Colaizzo, D
    Giuliani, N
    Vecchione, G
    Grandone, E
    Margaglione, M
    DiMinno, G
    THROMBOSIS AND HAEMOSTASIS, 1997, : O1594 - O1594
  • [38] Independence of growth factor induced plasminogen activator inhibitor type-1 (PAI-1) expression from the 4G/5G polymorphism of the PAI-1 gene
    Nordt, TK
    Eschenfelder, E
    Peter, K
    Sobel, BE
    Bode, C
    THROMBOSIS AND HAEMOSTASIS, 2003, 90 (01) : 36 - 42
  • [39] Influence of PAI-1 promoter 4G/5G genotype on the plasmatic PAI-1 levels in patients with deep vein thrombosis
    Seguí, R
    Estellés, A
    Mira, Y
    Villa, P
    Falcó, C
    España, F
    Vaya, A
    Grancha, S
    Aznar, J
    THROMBOSIS AND HAEMOSTASIS, 1999, : 431 - 431
  • [40] Attenuation of PAI-1 synthesis by troglitazone in human arterial smooth muscle cells is affected by the 4g/5g polymorphism in the promoter of the PAI-1 gene
    Nordt, TK
    Eschenfelder, E
    Peter, K
    Sobel, BE
    Bode, C
    CIRCULATION, 2000, 102 (18) : 47 - 47